Meeting News

Intensive therapy increases survival in patients with AML

March 1, 2017
SAN DIEGO — Patients with newly diagnosed acute myeloid leukemia treated with intensive therapy demonstrated higher 2-year overall survival…
Meeting News

Researchers identify factors associated with survival in patients with blast phase CML

February 24, 2017
“Previously unknown” prognostic factors – including older age at diagnosis, high bone marrow blast percentage, higher LDH levels…
Meeting News

Long-term morbidity, mortality increased after allogeneic HCT in patients with CML

February 20, 2017
SAN DIEGO — Patients who received allogeneic hematopoietic cell transplantation to treat chronic myeloid leukemia demonstrated similar…
Meeting News

Inotuzumab ozogamicin, low-intensity chemotherapy combination safe in older patients with leukemia

February 10, 2017
SAN DIEGO — Elderly patients with acute lymphoblastic leukemia demonstrated safe and encouraging results in the frontline setting after…
Meeting News

4SCAR19-modified T cells appear effective in chemotherapy-resistant patients with leukemia

February 9, 2017
SAN DIEGO — A fourth generation, safety-improved CD19–specific chimeric antigen receptor T-cell treatment option demonstrated safe and…
Meeting News

Pevonedistat, azacitidine combination well tolerated in AML

February 3, 2017
SAN DIEGO — Adding pevonedistat to azacitidine demonstrated durable remissions and notable response rates with limited additional toxicity…
Meeting NewsVideo

VIDEO: Advances in CAR T cells offer significant potential for patients with leukemia

January 19, 2017
SAN DIEGO — The use of a fourth-generation CAR T-cell therapy demonstrated high remission rates and appeared well tolerated in children and…
Meeting News

Adding nelarabine to hyper-CVAD appears safe, effective in adults with T-ALL

January 12, 2017
SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response and complete remission rates in…
Meeting News

Combination therapy with selinexor appears safe, effective in AML

January 12, 2017
SAN DIEGO — The use of selinexor in combination with high-dose cytarabine and mitoxantrone demonstrated promising overall response rates in…
Meeting News

Long-term ibrutinib use demonstrates increased survival in leukemia

January 6, 2017
SAN DIEGO — Ibrutinib monotherapy resulted in a significant median progression-free survival benefit in patients with relapsed or refractory…